180
Participants
Start Date
October 31, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
fipamezole
Fipamezole in Zydis formulation three times per day for up to 28 days
Biomedical Research Alliance of New York, Forest Hills
Maryland Parkinson's Disease and Movement Disorder Center, Baltimore
Duke Health Center at Morreene Road, Durham
Emory Healthcare, Atlanta
Medical College of Georgia, Augusta
Sunrise Clinical Research, Hollywood
Pharmax Research Clinic, Miami
University of Miami, Miami
Parkinson's Disease and Movement Disorder Center, Boca Raton
University of South Florida, Parkinson's Disease and Movement Center, Tampa
Collier Neurological Clinic, Naples
University of Alabama at Birmingham, Birmingham
Neurology Clinic PC, Northport
Semmes Murphey Neurologic and Spine Institute, Memphis
Henry Ford Health Systems, Franklin Pointe Medical Center, Southfield
Struthers Parkinson's Center, Golden Valley
Rush University Medical Center, Chicago
Parkinson Disease Center - University of Kansas Medical Center, Kansas City
Ochsner Clinic Foundation, New Orleans
Baylor College of Medicine, Houston
Neurology Associates, San Antonio
Colorado Neurological Institute, Englewood
Coastal Neurological Medicine Group, La Jolla
University of California Irvine, Irvine
Parkinson and Movement Disorder Institute, Fountain Valley
Max Superspecialty Hospital, Saket
Chatrapati Sahuji Maharaj Medical University, Lucknow
Neurology centre, Ahmedabad
University of Arizona Health Sciences Center, Tucson
U Mass Memorial Medical Center, Worcester
Neurology Group of Bergen County, Ridgewood
Oregon Health and Science University, Portland
St John's Medical College & Hospital, Bangalore
M S Ramaiah Medical College Hospital, Bangalore
Nizam's Institute of Medical Sciences, Hyderabaad
J.S.S. Medical College and Hospital, Mysore
Lead Sponsor
Collaborators (1)
Santhera Pharmaceuticals
INDUSTRY
Juvantia Pharma Ltd
INDUSTRY